E20 Capital Ltd purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 1st quarter, Holdings Channel reports. The fund purchased 303,925 shares of the company’s stock, valued at approximately $33,310,000. Astera Labs comprises about 3.1% of E20 Capital Ltd’s holdings, making the stock its 11th largest position.
A number of other large investors have also modified their holdings of the company. Lido Advisors LLC boosted its stake in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the period. Perigon Wealth Management LLC increased its stake in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after purchasing an additional 73 shares during the period. Sound Income Strategies LLC increased its stake in shares of Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after buying an additional 84 shares during the last quarter. Finally, Goldstein Advisors LLC boosted its position in shares of Astera Labs by 5.8% during the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on ALAB. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday. Susquehanna increased their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Evercore reissued an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Finally, UBS Group lifted their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $282.00.
Astera Labs Trading Up 20.0%
Shares of Astera Labs stock opened at $299.69 on Friday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a market cap of $51.37 billion, a PE ratio of 202.49, a price-to-earnings-growth ratio of 2.89 and a beta of 3.66. The company’s 50-day moving average price is $359.89 and its two-hundred day moving average price is $229.21.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the completion of the transaction, the director directly owned 57,466 shares in the company, valued at $25,859,700. This represents a 5.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,676,845 shares of company stock valued at $444,928,806. Corporate insiders own 10.40% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
